Caxton Associates (New York)’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
Other funds holding INGN
NHAS
BCM
FAM
Caxton Associates (New York)'s INGN Position: Q4 2018 in Review
Caxton Associates (New York) sold out of Inogen (INGN) in Q4 2018, closing a stake of 1,457 shares — an estimated $356K sold.
Caxton Associates (New York) first reported a position in INGN in Q1 2017 and held it in 3 quarters. The position peaked at $416K in Q2 2017. 271 funds tracked by Wall St. Rank hold INGN as of Q4 2018.
- Caxton Associates (New York) reported no remaining Inogen position as of Q4 2018 after selling out during the quarter.
- Caxton Associates (New York) sold 1,457 Inogen shares in Q4 2018, an estimated $356K.
- Caxton Associates (New York) first reported a position in Inogen in Q1 2017 and held it in 3 quarters.
- Caxton Associates (New York)'s Inogen position peaked at $416K in Q2 2017.
- 271 funds tracked by Wall St. Rank held Inogen as of Q4 2018.
Based on Caxton Associates (New York)'s 13F filing for Q4 2018, filed 14 Feb 2019.